Kanawha Capital Management’s Invesco BulletShares 2023 Corporate Bond ETF BSCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-29,750
Closed -$630K 210
2023
Q2
$630K Sell
29,750
-1,000
-3% -$21.1K 0.06% 134
2023
Q1
$648K Sell
30,750
-30,900
-50% -$650K 0.06% 130
2022
Q4
$1.29M Sell
61,650
-8,950
-13% -$187K 0.13% 98
2022
Q3
$1.47M Sell
70,600
-7,400
-9% -$155K 0.16% 89
2022
Q2
$1.63M Buy
78,000
+950
+1% +$20K 0.17% 88
2022
Q1
$1.63M Sell
77,050
-1,200
-2% -$25.5K 0.14% 92
2021
Q4
$1.68M Buy
78,250
+18,400
+31% +$397K 0.14% 93
2021
Q3
$1.3M Buy
59,850
+14,050
+31% +$305K 0.12% 100
2021
Q2
$995K Buy
45,800
+15,950
+53% +$347K 0.09% 113
2021
Q1
$650K Buy
29,850
+5,550
+23% +$121K 0.06% 128
2020
Q4
$532K Buy
24,300
+5,500
+29% +$120K 0.05% 136
2020
Q3
$410K Buy
+18,800
New +$411K 0.05% 143

Other funds holding BSCN

Kanawha Capital Management's BSCN Position: Q3 2023 in Review

Kanawha Capital Management sold out of Invesco BulletShares 2023 Corporate Bond ETF (BSCN) in Q3 2023, closing a stake of 29,750 shares — an estimated $630K sold.

Kanawha Capital Management first reported a position in BSCN in Q3 2020 and held it in 12 quarters. The position peaked at $1.68M in Q4 2021. 321 funds tracked by Wall St. Rank hold BSCN as of Q3 2023.

  • Kanawha Capital Management reported no remaining Invesco BulletShares 2023 Corporate Bond ETF position as of Q3 2023 after selling out during the quarter.
  • Kanawha Capital Management sold 29,750 Invesco BulletShares 2023 Corporate Bond ETF shares in Q3 2023, an estimated $630K.
  • Kanawha Capital Management first reported a position in Invesco BulletShares 2023 Corporate Bond ETF in Q3 2020 and held it in 12 quarters.
  • Kanawha Capital Management's Invesco BulletShares 2023 Corporate Bond ETF position peaked at $1.68M in Q4 2021.
  • 321 funds tracked by Wall St. Rank held Invesco BulletShares 2023 Corporate Bond ETF as of Q3 2023.

Based on Kanawha Capital Management's 13F filing for Q3 2023, filed 26 Oct 2023.